Stay ConnectedThe AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.
Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups – uncovering trends, use-cases, and best practices for practical AI adoption.
Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise
Copyright: © Daniel Faggella, 2014
Today's guest is Robert Rose, Senior Director of North America Customer Support at Adobe. Robert joins our conversation today to discuss the evolution of AI in customer interactions and the challenges organizations face when scaling these solutions across diverse customer bases. He shares insights on how AI-driven bots have progressed from basic transactional tools to more sophisticated systems capable of detecting customer emotions and improving responses over time. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
Today's guest is Panos Karelis, Director of Customer Experience and Insights at Intelligencia AI. Intelligencia AI is a life sciences technology company that uses proprietary data, biomedical expertise, and AI-driven algorithms to assess the probability of technical and regulatory success for drug candidates, helping pharmaceutical companies make informed decisions on which drugs to advance or discontinue. Panos joins us on today's show to explore the key challenges and opportunities in AI adoption for drug development. He discusses the "black box" problem in AI and the importance of transparency and explainability in building trust. Panos also highlights the role of high-quality, harmonized data in generating accurate AI-driven insights and the mindset shift required for organizations to integrate AI-assisted decision-making successfully. Additionally, he explains how AI can optimize clinical trial design, enhance portfolio management, and improve business development and licensing decisions. This episode is sponsored by Intelligencia AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
Today's guest is Mark McLaughlin, Director of Insurance in IBM's Global Industries Unit. Mark joins the podcast to discuss the biggest challenges insurers face today and how AI is transforming workflows, risk management, and customer experience. Later, he and Emerj Managing Editor Matthew DeMello explore why insurers are embracing a mix of on-premise and cloud-based strategies, managing multiple AI models to optimize business processes while maintaining security and cost efficiency. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research, streamlining scientific workflows, and enabling better decision-making in pharmaceutical R&D. Liran shares insights into the biggest challenges facing drug discovery today, including the complexity of disease biology and the critical role AI plays in unraveling it. He breaks down how AI-driven knowledge graphs, ontological models, and multimodal AI systems are improving both the speed and quality of scientific research. This episode is sponsored by BenchSci. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
Today's guest is Oleg Savin, Enterprise Architect and MES Expert at Unilever. Oleg is a frequent guest speaker at manufacturing conferences worldwide, including this year's Smart Manufacturing Excellence Summit in Munich. He joins us for the first of two episodes on the program today to explain why neurobiological and cybernetic AI capabilities have distinct advantages in manufacturing use cases and why it's imperative for industrial leaders to understand the difference. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
Today's guest is Ken Mertzel, Global Industry Leader in Financial Services at Automation Anywhere. Automation Anywhere is a global software company that develops various automation software for major industries. Before joining Automation Anywhere six years ago, Ken spent his career in the financial sector, including 15 years at Bank of America. There, he served as CFO of the insurance division and held various leadership roles in finance, risk management, and consumer operations, ultimately leading financial operations for the bank. Before that, he was part of Accenture's Financial Services Strategy practice, advising clients on industry-leading financial strategies. Ken joins us on this week's program to explore the evolution of automation in heavily regulated industries. He explains why traditional RPA has only been able to automate a fraction of tasks and how AI is unlocking new opportunities. Ken also breaks down how agentic automation is transforming key financial processes, from AML investigations to fraud detection and underwriting. By combining AI with automation, organizations can extract valuable insights, streamline decision-making, and create more interactive, human-in-the-loop systems. This episode is sponsored by Automation Anywhere. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
Today's guest is Roenen Ben-Ami, Co-founder and Chief Risk Officer of Justt. Justt is an AI-driven tech company whose platform helps retail leaders and merchants reduce loss from chargebacks with automation and friendly fraud prevention. Roenen joins us on today's podcast to break down the complexities of chargebacks and how AI-driven automation can help merchants recover lost funds at scale. Together with Emerj Managing Editor Matthew DeMello, Roenen helps explain the "guilty until proven innocent" nature of chargebacks, the rise of friendly fraud, and why merchants often leave money on the table due to inefficiencies in the dispute process. He details how Justt's proprietary approach—leveraging data enrichment, dynamic arguments, and automation—creates tailored chargeback responses that maximize win rates while reducing manual effort. This episode is sponsored by Justt. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
Today's guest is Kimberly Powell, Vice President of Healthcare and Life Sciences at NVIDIA. Kimberly joins us to discuss how AI is reshaping the healthcare landscape. As generative AI adoption accelerates, Kimberly shares her insights on the major challenges the healthcare industry faces, particularly in terms of technology infrastructure. Together, we explore the critical need for hybrid strategies that blend on-premise and cloud computing, enabling real-time data processing for medical imaging, clinical operations, and more. Kimberly emphasizes the importance of developing infrastructure capable of supporting these advanced AI applications to improve patient care and operational efficiency. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.
Today's guests are two senior executives from Sanofi's manufacturing division, Head of Data & AI for Manufacturing & Supply Chain Kartik Pant and Head of AI & Data Products, Manufacturing & Supply Shreyas Becker, respectively. Together they return to the podcast to cover the challenges and opportunities in adopting data infrastructure and AI solutions in life sciences manufacturing. Throughout the episode they emphasize the need for a unified data architecture, starting small, and articulating a problem-driven approach to technology adoption. Kartik and Shreyas also discuss the importance of understanding specific use cases and leveraging data to identify areas for optimizing processes. If you're interested in unlocking our AI best practice guides, frameworks for AI ROI, and specific resources for AI consultants, visit emerj.com/p1.
Today's guest is Paul Cuglietta, Head of Contact and Claims at Simplyhealth. Simplyhealth is a health insurance provider based in the UK whose history goes back to the late 1800s. Paul joins today's discussion to unpack the challenges organizations face when driving digital transformation. With nearly two years of AI integration experience, Paul provides unique insights from his time at Simplyhealth into overcoming internal and external hurdles in their transformation journey. This episode is sponsored by Hyperscience. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
Our TOPPODCAST Picks 
